Accueil / Tag Archives: Research

Tag Archives: Research

Dr. Robert Emery Joins HealthTech Solutions as Chief Scientific Officer

Tuesday, September 19th 2017 at 3:00pm UTC IOWA CITY, Iowa–(BUSINESS WIRE)– Emerging health IT start-up HealthTech Solutions has named Robert Emery MD as Chief Scientific Officer. Dr. Emery will oversee the company’s research, funded by a recent SBIR Phase 1 grant, on using intelligent communication technology to reduce organ waste …

Plus »

Ignyta to Present at Cantor Fitzgerald 2017 Global Healthcare Conference

Wednesday, September 20th 2017 at 11:00am UTC SAN DIEGO–(BUSINESS WIRE)– Ignyta, Inc. (Nasdaq: RXDX), a biotechnology company focused on precision medicine in oncology, announced today that Jacob Chacko, M.D., its Chief Financial Officer, will make a presentation at the Cantor Fitzgerald 2017 Global Healthcare Conference on Wednesday, September 27, 2017, at …

Plus »

Gene Editing Technology Developer Awarded $500,000 Lemelson-MIT Prize

Tuesday, September 19th 2017 at 1:00pm UTC Feng Zhang Recognized for Commitment to Invention, Collaboration and Mentorship CAMBRIDGE, Mass.–(BUSINESS WIRE)– Dr. Feng Zhang, a pioneer of the revolutionary CRISPR gene editing technology, TAL effectors, and optogenics, has just been announced as the recipient of the 2017 $500,000 Lemelson-MIT Prize, the …

Plus »

InGeneron Announces Publication of Positive Results from Investigator-Initiated Wound Healing Case Series Using Company’s Regenerative Cell Technology

Monday, September 18th 2017 at 10:00am UTC Point-of-care regenerative cell therapy demonstrates promising safety and tolerability profile and closure of venous chronic leg wounds as conducted by Technical University Munich HOUSTON, Texas & MUNICH–(BUSINESS WIRE)– InGeneron, Inc., a regenerative medicine and biotechnology company, today announced the publication of results from …

Plus »

Merck to Advance Bispecific Antibody Drug Candidate Developed Using Zymeworks’ Azymetric™ Platform into Preclinical Development

Tuesday, September 19th 2017 at 9:00am UTC VANCOUVER, British Columbia–(BUSINESS WIRE)– Zymeworks Inc. (“Zymeworks”), (NYSE: ZYME; TSX: ZYME) a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation bispecific and multifunctional biotherapeutics, today announced that Merck (known as MSD outside the US and Canada) has provided formal …

Plus »

Puma Biotechnology to Present at Cantor Fitzgerald Healthcare Conference

Monday, September 18th 2017 at 8:20pm UTC LOS ANGELES–(BUSINESS WIRE)– Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will provide an overview of the Company, including recent developments, at 1:40 p.m. EDT on Tuesday, September 26, …

Plus »

Scientist.com Partners with Top Pharma to Launch COMPLI™, a Global Compliance Standard for Human Biosample Acquisition

Thursday, September 21st 2017 at 12:06pm UTC Sourcing of high-risk services made easier with Scientist.com’s new COMPLI™ feature SAN DIEGO–(BUSINESS WIRE)– Scientist.com, the world’s leading marketplace for outsourced scientific services, today announced the launch of a global process for the ethical sourcing of human biosamples using its COMPLI™ functionality. Created …

Plus »

F-Prime Capital Announces Joshua Grass as New Entrepreneur-in-Residence

Wednesday, September 20th 2017 at 11:30am UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– F-Prime Capital, a global venture capital firm focused on investments in healthcare and technology, today announced that Joshua Grass has joined the firm as entrepreneur-in-residence. Mr. Grass will primarily focus on advancing life sciences company-creation activities at F-Prime. “We are excited …

Plus »

Amylyx Pharmaceuticals Receives FDA Orphan Drug Designation for AMX0035 for the Treatment of Amyotrophic Lateral Sclerosis

Tuesday, September 19th 2017 at 1:00pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– Amylyx Pharmaceuticals, Inc., announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to AMX0035, an oral therapeutic in clinical development for the treatment of amyotrophic lateral sclerosis (ALS). The Company recently began a Phase …

Plus »
Macbook Pro
* Intel Core i7 (3.8GHz, 6MB cache)
* Retina Display (2880 x 1880 px)
* NVIDIA GeForce GT 750M (Iris)
* 802.11ac Wi-Fi and Bluetooth 4.0
* Thunderbolt 2 (up to 20Gb/s)
* Faster All-Flash Storage (X1)
* Long Lasting Battery (9 hours)
BIENVENUE CHEZ BIOTECH FINANCES
Vous appréciez nos informations ?
Recevez nos alertes, nos dernières actualités, suivez-nous, enregistrez-vous gratuitement, rejoignez notre communauté. Merci à vous !
ARE YOU READY? GET IT NOW!
Increase more than 500% of Email Subscribers!
Your Information will never be shared with any third party.
DÉCOUVREZ LA SOLUTION STRATA !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cuZWVpLWJpb3RlY2hmaW5hbmNlcy5jb20vd3AtY29udGVudC91cGxvYWRzLzIwMTUvMDcvU2F0cmEtMi5tcDQiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
Retrouvez nous sur http://stratahealth.com/fr/
Un ensemble de solutions performantes
pour assurer le continuum de vos données.
Biotech Finances
SUIVEZ-NOUS, ENREGISTREZ-VOUS !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cueW91dHViZS5jb20vZW1iZWQvajhsU2NITzJtTTAiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
All rights reserved © Company Name, 2014
Concours Genopole Young Biotech Award
* 100 000 € pour la meilleure Biotech
* Réservé aux biotechs hors santé
* 6 mois d'hébergement gratuit
* Un accompagnement personnalisé
* Etude de marché offerte
* Expertise du projet par EY
* Et nombre d'autres avantages...